Ignite Creation Date:
2025-12-25 @ 12:52 AM
Ignite Modification Date:
2026-01-25 @ 12:42 AM
Study NCT ID:
NCT01668667
Status:
COMPLETED
Last Update Posted:
2021-05-24
First Post:
2012-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study
Sponsor:
XenoPort, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
114025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None